Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- Stay skeptical, not negative; practical, not bearish. That was Jim Cramer's advice to his Mad Money viewers Monday, as he recapped the 10 reasons why the market was able to stage at least a one-day rally.
1. The markets were oversold, down for seven days in a row.
2. Things in China are so bad, it's clear the Chinese government will soon need to do even more to help things along.
4. Europe is rallying behind getting a Greek aid package passed, despite interference from Germany.
5. The strong U.S. dollar finally showed some weakness.
6. Inflation remains tame, making it silly for the Federal Reserve to raise interest rates in the near term.
7. Oil was able to bounce off its lows.
8. The rotation is for real, and investors snapped up the recession-proof stocks as they headed lower.
Do any of these reasons mean the market can extend its rally tomorrow? Probably not, Cramer admitted, but it's good to know that if conditions are right, stocks still can head higher.
What to Buy Next
Even on up days like today, it's always prudent to do some thinking about what will rally next, Cramer told viewers. That's why he always circles back to the new highs list for ideas. Among last week's big winners, Cramer identified eight themes investors should take notice of.
First are the food and beverage stocks, which prosper from cheaper commodity prices. Among the group, Cramer called out Whitewave Food (WWAV), an Action Alerts PLUS name, and General Mills (GIS - Get Report) as favorites.
Next are medical devices, where Henry Schein (HSIC - Get Report) is offering a rare buying opportunity. Home builders also made some new highs last week, with Lennar (LEN - Get Report) catching Cramer's eye. Meanwhile, over in the travel and leisure space, Cramer said to keep an eye on the cruise lines.
Information technology and insurance also topped the list last week. Cramer said Chubb (CB - Get Report) continues to shine in the insurance space. Athletic apparel stocks also rallied last week, but Cramer advised waiting for a pullback before pulling the trigger on this group.
All of these areas are big trends that can be bought on the next market downturn.
More on Cramer's Watch List
Just as the new high list can offer investors ideas, so, too, can the new low list. While most of the rubble on this list centers around oil and gas, Cramer identified seven stocks he said are worth nibbling at, assuming investors can take a little more pain before they begin to turn around.
First is Alcoa (AA - Get Report), a stock levered to China that ultimately won't be. Second is Applied Materials (AMAT - Get Report), also suffering from a summer tech slowdown. Third ias Entergy (ETR - Get Report), a great utility with a hefty 4.8% yield.
Also catching Cramer's eye is Loews (L - Get Report), the conglomerate that's now trading below book value due to its investment in Diamond Offshore (DO - Get Report). Also in the oil patch, Spectra Entergy (SE - Get Report), with a 5% yield, and Exxon Mobil (XOM - Get Report), which also will likely trade lower, but is a buy with a yield over 4%.
Executive Decision: Bob Ward
Ward touted the addition of Dr. Lorraine A. Fitzpatrick as Radius' chief medical officer as a big win for the company's osteoporosis developments, noting that she will be giving the marquee presentation at an upcoming conference.
Ward was also not worried about a recent denial for fast-track approval from the Food and Drug Administration. He said that fast-track applications are often denied, so this denial was not unexpected and a regular approval process suits Radius just fine.
Finally, when asked about the company's recent secondary offering of stock, Ward said Radius now has ample cash on hand for the continued development and launches of their upcoming pipeline. Radius is also seeking partners in some cases to also help offset costs where it can.
Cramer said that Radius remains a great story and offers investors multiple ways to win.
In the Lightning Round, Cramer was bullish on Enterprise Products Partners (EPD - Get Report), Dave and Busters (PLAY - Get Report), Helen of Troy (HELE - Get Report) and MGM Resorts (MGM - Get Report).
Cramer was bearish on MiMedx Group (MDXG).
Executive Decision: J. Joseph Kim
In his second "Executive Decision" segment, Cramer sat down with Dr. J. Joseph Kim, president and CEO of Inovio Pharmaceuticals (INO - Get Report), a stock that's roared up 26% over the past two days on the news of a partnership with AstraZeneca (AZN - Get Report) that could yield up to $700 million in milestone payments for the company.
Kim explained that Inovio's immunotherapy platform generates T-cells in the body that act as "Navy Seals" to seek out and eliminate cancer cells in the body. What makes their platform unique is Inovio's platform can target specific types of cancers better than anyone else.
Kim continued by noting that the same synthetic DNA technology can also be applied to everything from Hepatitis-C and HIV to influenza and Ebola.
When asked about their partnership, Kim said there were multiple suitors, but Inovio chose the best candidate that will allow them to grow and expand their pipeline even faster.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.